Chapman Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Chapman Financial Group's BMY Position: Q3 2026 in Review
Chapman Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 28% in Q3 2026, selling an estimated $53.4K and leaving 2,200 shares worth $137K. The position accounts for 0.09% of the portfolio, ranked #143.
Chapman Financial Group first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $496K in Q4 2024. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Chapman Financial Group held 2,200 shares of Bristol-Myers Squibb worth $137K as of Q3 2026.
- Chapman Financial Group sold 845 Bristol-Myers Squibb shares in Q3 2026, an estimated $53.4K.
- Bristol-Myers Squibb made up 0.09% of Chapman Financial Group's portfolio in Q3 2026, its #143 holding.
- Chapman Financial Group first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Chapman Financial Group's Bristol-Myers Squibb position peaked at $496K in Q4 2024.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Chapman Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.